These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 391624)

  • 1. A multicentre general practice study of cinnarizine in the treatment of peripheral vascular disease.
    Donald JF
    J Int Med Res; 1979; 7(6):502-6. PubMed ID: 391624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent claudication: a controlled study in parallel time of the short-term and long-term effects of cinnarizine.
    Barber JH; Reuter CA; Jageneau AH; Loots W
    Pharmatherapeutica; 1980; 2(6):401-7. PubMed ID: 7433479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of physical training and flunarizine on walking capacity in intermittent claudication.
    Lepäntalo M; Sundberg S; Gordin A
    Scand J Rehabil Med; 1984; 16(4):159-62. PubMed ID: 6397852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intermittent claudication. Attempt at an objective vue of the disease and the possible treatment results with Sibelium].
    Loots W; Dom J; Hörig C
    Med Welt; 1980 Feb; 31(5):189-92. PubMed ID: 7366398
    [No Abstract]   [Full Text] [Related]  

  • 5. [Flunarizine in the treatment of arteriopathies of the legs].
    Catalano M; Sacchi E; Tomasini M; Coazzoli E; Parolini A; Dall'Oglio A; Libretti A
    Ric Clin Lab; 1985; 15 Suppl 1():475-8. PubMed ID: 4035228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic urticaria with an inhibitor of complement activation (cinnarizine).
    Kalimo K; Jansen CT
    Ann Allergy; 1980 Jan; 44(1):34-7. PubMed ID: 7352689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind placebo controlled study of cinnarizine in the prophylaxis of seasickness.
    Hargreaves J
    Practitioner; 1980 May; 224(1343):547-50. PubMed ID: 6999486
    [No Abstract]   [Full Text] [Related]  

  • 8. Cinnarizine in the treatment of chronic asthma.
    Emanuel MB; Chamberlain JA; Whiting S; Rigden BG; Craven AH
    Br J Clin Pharmacol; 1979 Feb; 7(2):189-95. PubMed ID: 367414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responsiveness of various symptoms of vascular disorders to calcium antagonist.
    Verhaegen H; Reyntjens A; Horig C; Pötsch W
    Angiology; 1979 Jul; 30(7):447-53. PubMed ID: 380409
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-blind placebo-controlled studies with flunarizine in venous insufficiency.
    Roeckaerts F; Vanden Bussche G
    Angiology; 1980 Dec; 31(12):833-45. PubMed ID: 7008658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication.
    Di Perri T; Guerrini M
    Angiology; 1983 Jan; 34(1):40-5. PubMed ID: 6824189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E; Bahnini A; Mouren X; Gamand S
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG; Gresele P; Ferrari G; Santoro L; Gianese F;
    Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
    Blume J; Kieser M; Hölscher U
    Vasa; 1996; 25(3):265-74. PubMed ID: 8967154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication.
    Perhoniemi V; Salmenkivi K; Sundberg S; Johnsson R; Gordin A
    Angiology; 1984 Jun; 35(6):366-72. PubMed ID: 6375469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarpogrelate, a 5-hT2A receptor antagonist in intermittent claudication. A phase II European study.
    Norgren L; Jawien A; Mátyás L; Riegerd H; Arita K;
    Vasc Med; 2006 May; 11(2):75-83. PubMed ID: 16886837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Padma-28, a herbal preparation, increases walking distance in patients with intermittent claudication].
    Drabaek H; Mehlsen J; Petersen JR; Himmelstrup H; Hansen KF
    Ugeskr Laeger; 1994 Oct; 156(42):6207-9. PubMed ID: 7998359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled study of the effects of policosanol in patients with intermittent claudication.
    Castaño G; Más R; Roca J; Fernández L; Illnait J; Fernández JC; Selman E
    Angiology; 1999 Feb; 50(2):123-30. PubMed ID: 10063942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study.
    Pytel J; Nagy G; Tóth A; Spellenberg S; Schwarz M; Répassy G
    Clin Ther; 2007 Jan; 29(1):84-98. PubMed ID: 17379049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of walking distance by defibrotide in patients with intermittent claudication--results of a randomized, placebo-controlled study (the DICLIS study). Defibrotide Intermittent CLaudication Italian Study.
    Violi F; Marubini E; Coccheri S; Nenci GG
    Thromb Haemost; 2000 May; 83(5):672-7. PubMed ID: 10823260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.